Results 311 to 320 of about 821,630 (331)

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

CNS & Neurological Disorders - Drug Targets, 2009
In the past decade there has been increasing interest in the potential benefit of early pharmacological intervention in schizophrenia. Patients with schizophrenia show nonpsychotic and nonspecific prodromal symptoms (e.g., depression and cognitive deficits) for several years preceding the onset of frank psychosis. Several studies have demonstrated that
openaire   +2 more sources

Sigma receptors and neurological disorders

Pharmacological Reports, 2021
Agnieszka Piechal, Dagmara M Mirowska-Guzel   +1 more
exaly  

Antinociception by Sigma-1 Receptor Antagonists

2016
Luz Romero, Manuel Merlos, José Miguel Vela   +2 more
openaire   +1 more source

Sigma-1 Receptor Ligands

2009
openaire   +1 more source

Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy

Medicinal Research Reviews, 2012
Veronique Megalizzi, Christine Decaestecker   +1 more
exaly  

Sigma receptors: biology and therapeutic potential

Psychopharmacology, 2004
Xavier Codony
exaly  

Estimating sigma-1 receptor occupancy by PET

Neuroscience Research, 2011
Masatomo Ishikawa, Muneyuki Sakata, Kenji Ishii, Keiichi Oda, Kiichi Ishiwata, Masaomi Iyo, Kenji Hashimoto   +6 more
openaire   +1 more source

Sigma receptors as potential therapeutic targets for neuroprotection

European Journal of Pharmacology, 2014
Linda Nguyen
exaly  

Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival

Cell, 2007
Tsung-Ping Su
exaly  

The expression and functional characterization of sigma (σ) 1 receptors in breast cancer cell lines

Cancer Letters, 2006
Pinar Uysal-Onganer
exaly